Clinical Trial Update: Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intramyocardial injection of mesenchymal precursor cells in heart failure patients receiving an LVAD; study terminated with posted resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Mesenchymal precursor cells (mesenchymal precursor cells)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Heart Failure | Phase 2 | Status: TERMINATED | Results posted: 2019-03-05